Rash after a medication change

2021 ◽  
Vol 70 (6) ◽  
Author(s):  
Karnes
Keyword(s):  
Medication Change

The older patient presenting with itch and a recent medication change

2020 ◽  
Vol 49 (5) ◽  
pp. 277-279
Author(s):  
Lauren Maree Turner ◽  
Shelley Ji Eu Hwang ◽  
Genevieve Bennett ◽  
Andrew C Miller
Keyword(s):  
Older Patient ◽  
Medication Change

Massive Eosinophilic Reaction to Desipramine in Conjunction with Pneumonia*

1984 ◽  
Vol 29 (2) ◽  
pp. 142-144 ◽  
Author(s):  
R.P. Kraus ◽  
R.J. Clarke ◽  
R.A. Remick
Keyword(s):  
Affective Disorder ◽  
Female Patient ◽  
Blood Count ◽  
Bipolar Affective Disorder ◽  
Dry Mouth ◽  
White Blood Count ◽  
Medication Change ◽  
Supportive Management

The authors report on a female patient with bipolar affective disorder who presented with marked eosinophilia in conjunction with pneumonia five days after a medication change from amitriptyline to desipramine (for intolerable dry mouth). She improved with discontinuance of medications and supportive management, and her eosinophilia normalized. Reinstitution of desipramine was followed by prompt appearance of asymptomatic eosinophilia, which resolved with discontinuation of desipramine. A subsequent depression managed with amitriptyline was followed by no abnormal white blood count findings. Eosinophilia is occasionally encountered in imipramine or desipramine therapy and, although usually asymptomatic, appears to be manageable by switching to amitriptyline or nortriptyline.

Abstract P395: High Risk Diabetics Risk of Recurrent Stroke and Cardiovascular Disease Persists Even With Patient Personalized Subspecialty Care

Stroke ◽  
2021 ◽  
Vol 52 (Suppl_1) ◽  
Author(s):  
Hannah Branstetter ◽  
Natalie Buchwald ◽  
Esther Olasoji ◽  
Meghan Humbert ◽  
Rondalyn Dickens ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Nursing Education ◽  
High Risk ◽  
Cardiovascular Event ◽  
Stroke Prevention ◽  
Diabetes Education ◽  
Reperfusion Therapy ◽  
Interquartile Range ◽  
Medication Change

Introduction: Diabetes management is an important aspect of stroke prevention. To our knowledge, studies that focus specifically on the role of multidisciplinary teams for adjusting diabetes medications and diabetes education for stroke and cardiovascular disease prevention to compliment standard stroke prevention and nursing education are lacking. Here we sought to evaluate whether high risk diabetics, hemoglobin A1c (HA1c) > 8%, admitted secondary to stroke would benefit from a multidisciplinary team model that also incorporates endocrinology consultation and diabetes education to personalized nursing education and education and management of the admitting service. Methods: Data was obtained from our Institutional Review Board approved stroke admission database from 2017 to November 2019. Regression analysis was used to identify significant associations between diabetes education (DE) and endocrine consultation (EC) with readmission rates with 30 days, re-admission within 30 days secondary to stroke, cardiovascular event or stroke within a year of the stroke admission, and medication change after controlling for age, sex, NIHSS, HbA1c, low density lipoprotein (LDL), reperfusion therapy for acute stroke. Follow-up HbA1c post hospitalization was available for only 17% of the population, and was not included in the regression models. Results: A total of 202 patients were included, median age 66 (interquartile range 56-75), 43% women, NIHSS median 5 (interquartile range (IQR, 2-9), LDL median 105 (IQR, 69-155), A1c median 9.5 (IQR, 8.5 -11.1), and 24% received reperfusion therapy. EC was associated with higher likelihood of a medication change (odds ratio (OR) 9.43, 95% confidence interval (CI) (3.22-30.69). DE was associated with younger age (OR 0.96, 95% CI 0.92-0.99); higher A1c value (OR 1.47, 95% CI 1.18 - 1.87) and higher likelihood of cardiovascular event within a year of the stroke (OR 3.38, 95% CI 1.23 - 9.70). Conclusion: While the endocrine consultation does lead to medications changes with the intent of improving post discharge glycemic control, cardiovascular events were still more likely, possibly from DM disease severity. Further continuation of follow up of these patients with EC and DE after hospital discharge may be needed.

Medication change as an outcome: developing the Medication Change Questionnaire

2010 ◽  
Vol 8 (4) ◽  
pp. 526-527 ◽  
Author(s):  
C Paterson ◽  
L Symons ◽  
N Britten ◽  
J Bargh
Keyword(s):  
Medication Change

Developing the Medication Change Questionnaire

2004 ◽  
Vol 29 (4) ◽  
pp. 339-349 ◽  
Author(s):  
C. Paterson ◽  
L. Symons ◽  
N. Britten ◽  
J. Bargh
Keyword(s):  
Medication Change

POE01 Outcome of medication change in patients with refractory epilepsy

2010 ◽  
Vol 81 (11) ◽  
pp. e45-e46
Author(s):  
S. H. Wong ◽  
D. F. Smith ◽  
A. G. Marson
Keyword(s):  
Refractory Epilepsy ◽  
Medication Change

Predictors of antipsychotic medication change

2005 ◽  
Vol 32 (1) ◽  
pp. 85-94 ◽  
Author(s):  
Michael J. Sernyak ◽  
Douglas Leslie ◽  
Robert Rosenheck
Keyword(s):  
Antipsychotic Medication ◽  
Medication Change
Sign in / Sign up

Export Citation Format

Share Document